Logos Global Management LP 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-22 12:27 pm Purchase |
2020-06-16 | 13G | Celldex Therapeutics, Inc. CLDX |
Logos Global Management LP | 1,700,000 4.300% |
1,700,000 (New Position) |
Filing |